InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,956.24
(
-1.10%
)
US TECH 100
16,586.80
(
-2.06%
)
Dow Jones
37,923.95
(
0.39%
)
Brent Oil
86.71
(
0.34%
)
Bitcoin
64,124.13
(
0.97%
)
Post# of 29232
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119435
Boards Moderated 16
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biotech_researcher post# 14034

Thursday, 01/19/2017 4:31:59 PM

Thursday, January 19, 2017 4:31:59 PM

Post# of 29232

I really like AQB market cap, but question they have the ability to scale their business.

We won't know that for a while; for now, AQB's main hurdle is launching the product when the first cohort of post-approval fish are large enough to be processed.

The valuation is relatively low for several reasons, including the one you mentioned. However, the business is strongly thematic for this message board. The immense success of MHG is an indication of what might be possible, in due course.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up